BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Don’t ask for “BHRT” or “traditional HRT” as a brand — ask for an evidence‑based regimen tailored to your symptoms and health risks.
• If you want the closest thing to “bioidentical” with good safety data, ask about FDA‑approved estradiol (transdermal patch or gel) plus micronized progesterone (Prometrium). If you have contraindications or prefer another option, your clinician can recommend an appropriate alternative.
• See a clinician with menopause expertise (NAMS‑certified provider, gynecologist, reproductive endocrinologist, or a dedicated menopause clinic such as Mayo Clinic or Cleveland Clinic) and use a reputable pharmacy. If a compounded product is required, use a PCAB‑accredited compounding pharmacy.

What “BHRT” and “traditional HRT” mean

• BHRT (bioidentical hormone replacement therapy) often refers to hormones that are chemically identical to human hormones (estradiol, progesterone). Some BHRT products are FDA‑approved (estradiol products, micronized progesterone), but many BHRT treatments are compounded in pharmacies and are not FDA‑regulated.
• Traditional HRT usually refers to older, brand-name products such as Premarin (conjugated equine estrogens) and Provera (medroxyprogesterone acetate), or to regimens using synthetic progestins.

Key differences and evidence

• FDA‑approved bioidentical products (oral or transdermal estradiol; micronized progesterone — Prometrium) have standardized dosing, clinical trial data, and manufacturing oversight.
• Compounded BHRT can be useful for people with specific allergy/absorption issues or dosing needs, but compounding has less oversight, batch variability, and fewer safety data.
• Some safety/relevance points:
  • Transdermal estradiol (patch/gel) appears to have lower risk of venous thromboembolism (VTE) than oral estrogen.
  • Micronized progesterone (Prometrium) may have a different safety profile than synthetic progestins (e.g., medroxyprogesterone), but evidence is still evolving.
  • Overall HRT risks (breast cancer, VTE, stroke, cardiovascular effects) depend on age, timing after menopause, dose, formulation, and individual risk factors.

Where and whom to see

• Providers: gynecologist, reproductive endocrinologist, primary care physician with menopause training, or a NAMS‑certified menopause practitioner. Ask whether they follow current menopause guidelines (NAMS, Endocrine Society).
• Clinics: large academic centers with menopause programs (for example, Mayo Clinic or Cleveland Clinic menopause clinics) or community menopause clinics with credentialed physicians.
• Pharmacies: for FDA‑approved products use any pharmacy. If you need compounded BHRT, choose a compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or recommended by a licensed clinician.

What to ask your clinician (practical script)

• “Can we review my menopausal symptoms, medical history, and risks (breast cancer, clotting, cardiovascular) and discuss HRT options?”
• “I’m interested in evidence‑based bioidentical options — for example transdermal estradiol (Vivelle‑Dot, Climara, Alora) and micronized progesterone (Prometrium). Are these appropriate for me?”
• “If a compounded BHRT is being suggested, can you explain why a commercial FDA‑approved product isn’t suitable, and will you use a PCAB‑accredited pharmacy? Can I see a certificate of analysis?”
• “Do you recommend baseline tests (mammogram, BP, lipids) and what follow‑up will you use to monitor benefit and risk?”

Brands and why (examples)

• Vivelle‑Dot, Climara, Alora (transdermal estradiol patches) — transdermal route, lower VTE risk than oral estrogen.
• Estrace (oral estradiol), Divigel/Estrogel (estradiol gels) — FDA‑approved estradiol formulations with known dosing and oversight.
• Prometrium (micronized progesterone) — FDA‑approved progesterone (bioidentical) used when a progestogen is needed to protect the uterus.
• Premarin + Provera historically used traditional regimens; ask about their specific risks and whether newer options are preferable for you.

What to avoid or be cautious about

• Avoid accepting compounding or saliva/urine hormone tests as necessary without clear medical justification — saliva testing to dose hormones is not supported by good evidence.
• Beware clinics that promise that “BHRT is completely safe” or that it reverses aging — these claims aren’t supported by strong evidence.
• If you have a history of breast cancer, active clotting disorder, or certain cardiovascular disease, HRT may be contraindicated — coordinate care with your oncologist or specialist.

Next steps

1. Book an appointment with a menopause‑knowledgeable clinician (look for NAMS certification or menopause clinic listing).
2. Bring a summary of your symptoms and medical/family history and say you’d like to discuss evidence‑based HRT options (mention transdermal estradiol + micronized progesterone if interested).
3. If your clinician recommends compounded BHRT, ask why and request a PCAB‑accredited pharmacy and quality certificates.

If you tell me your age, symptoms, and medical history (major issues like history of blood clots, breast cancer, smoking, or cardiovascular disease), I can suggest more specific questions to take to your clinician.